BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21272534)

  • 1. The role of information technology in the development of community pharmacy services: visions and strategic views of international experts.
    Westerling AM; Haikala V; Airaksinen M
    Res Social Adm Pharm; 2011 Dec; 7(4):430-7. PubMed ID: 21272534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
    Blake KB; Madhavan SS
    Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' perceptions of their role in asthma management and barriers to the provision of asthma services.
    Kritikos VS; Reddel HK; Bosnic-Anticevich SZ
    Int J Pharm Pract; 2010 Aug; 18(4):209-16. PubMed ID: 20636672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative study exploring community pharmacists' awareness of, and contribution to, self-care support in the management of long-term conditions in the United Kingdom.
    Ogunbayo OJ; Schafheutle EI; Cutts C; Noyce PR
    Res Social Adm Pharm; 2015; 11(6):859-79. PubMed ID: 25677228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional survey of community pharmacists' views of the electronic Minor Ailment Service in Scotland.
    Paudyal V; Hansford D; Scott Cunningham IT; Stewart D
    Int J Pharm Pract; 2010 Aug; 18(4):194-201. PubMed ID: 20636670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Providing patient care in community pharmacies: practice and research in Finland.
    Bell JS; Väänänen M; Ovaskainen H; Närhi U; Airaksinen MS
    Ann Pharmacother; 2007 Jun; 41(6):1039-46. PubMed ID: 17504836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing oral chemotherapy services in community pharmacies: a qualitative study of chemotherapy nurses' and pharmacists' views.
    Butt F; Ream E
    Int J Pharm Pract; 2016 May; 24(3):149-59. PubMed ID: 26671523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General practitioners' views of pharmacists' current and potential contributions to medication review and prescribing in New Zealand.
    Hatah E; Braund R; Duffull SB; Tordoff J
    J Prim Health Care; 2013 Sep; 5(3):223-33. PubMed ID: 23998173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical care in community pharmacies: practice and research in the US.
    Christensen DB; Farris KB
    Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Existing arrangements for monitoring community pharmacies in England: can they have a role in the revalidation of pharmacists?
    Jacobs S; Schafheutle EI; Jee SD; Elvey R; Hassell K; Noyce PR
    Res Social Adm Pharm; 2013; 9(2):166-77. PubMed ID: 23517658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician beliefs and attitudes toward collaboration with community pharmacists.
    Kucukarslan S; Lai S; Dong Y; Al-Bassam N; Kim K
    Res Social Adm Pharm; 2011 Sep; 7(3):224-32. PubMed ID: 21272527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New York State primary care physicians' attitudes to community pharmacists' clinical services.
    Bailie GR; Romeo B
    Arch Intern Med; 1996 Jul; 156(13):1437-41. PubMed ID: 8678712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.
    Saramunee K; Krska J; Mackridge A; Richards J; Suttajit S; Phillips-Howard P
    Res Social Adm Pharm; 2014; 10(2):272-84. PubMed ID: 23089293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opinion comparison concerning future information technology in Finnish community pharmacies.
    Westerling AM; Hynninen JT; Haikala VE; Airaksinen MS
    Pharm World Sci; 2010 Dec; 32(6):787-94. PubMed ID: 20848207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
    Wells KM; Thornley T; Boyd MJ; Boardman HF
    Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacists' experience and perceptions of the New Medicines Service (NMS).
    Lucas B; Blenkinsopp A
    Int J Pharm Pract; 2015 Dec; 23(6):399-406. PubMed ID: 25712253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient-centered pharmacy services model of HIV patient care in community pharmacy settings: a theoretical and empirical framework.
    Kibicho J; Owczarzak J
    AIDS Patient Care STDS; 2012 Jan; 26(1):20-8. PubMed ID: 22149903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.